Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (July 8, 2008). doi:10.1152/physiolgenomics.90247.2008
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Tiffin, N.
Right arrow Articles by Ramesar, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiffin, N.
Right arrow Articles by Ramesar, R.
Submitted on May 12, 2008
Revised on June 20, 2008
Accepted on July 7, 2008

Prioritisation of candidate disease genes for metabolic syndrome by computational analysis of its defining phenotypes

Nicki Tiffin1*, Ikechi Okpechi1, Carolina Perez-Iratxeta2, Miguel A. Andrade-Navarro3, and Rajkumar Ramesar1

1 University of Cape Town
2 Ottawa Health Research Institute
3 Ottawa Health Research Institute/University of Ottawa

* To whom correspondence should be addressed. E-mail: nickitiffin{at}imaginet.co.za.

There is a rapid increase in world-wide burden of disease attributed to metabolic syndrome, as defined by co-occurrence of an array of phenotypes including abdominal obesity, dysglycemia, hypertrigylceridemia, low levels of high density lipoprotein (HDL) cholesterol and hypertension. Familial studies clearly indicate a genetic component to the disease and many linkage studies have identified a large number of linked loci. No disease-causing genes, however, have been conclusively identified, most likely because this is a multigenic disease for which effects of many causative genes may be small and combined with environmental effects. To assist empirical identification of metabolic syndrome associated genes, we present here a novel computational approach to prioritise candidate genes. We have used linkage studies and the clinical and population-specific presentation of the disease to select a final candidate gene list of nineteen most likely disease-causing genes. These are predominantly involved in chylomicron processing, transmembrane receptor activity and signal transduction pathways. We propose here that information about the clinical presentation of a complex trait can be used to effectively inform computational prioritisation of disease-causing genes for that trait.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.